Platelet/lymphocyte ratio is a significant prognostic factor for targeted therapy in patients with EGFR-mutated non-small-cell lung cancer

OBJECTIVE: To analyze the prognostic significance of the pretreatment platelet/lymphocyte ratio (PLR) for targeted therapy in patients with epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC). METHODS: We conducted a retrospective study of 96 patients with EGFR-mutated...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kejun, Jiang, Guanming, Fang, Nianxin, Cai, Limin, Du, Wei, Jia, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758664/
https://www.ncbi.nlm.nih.gov/pubmed/33350871
http://dx.doi.org/10.1177/0300060520980205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758664/
https://www.ncbi.nlm.nih.gov/pubmed/33350871
http://dx.doi.org/10.1177/0300060520980205

Ejemplares similares